---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-003073"
form_type: "8-K"
ticker: "VIR"
cik: "0001706431"
company_name: "Vir Biotechnology, Inc."
filed_at: "2025-01-30T23:59:59+00:00"
generated_at: "2026-05-27T05:36:59.586425+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Vir Biotechnology CTO to depart Feb 26; Maninder Hora appointed as replacement

## Summary
- Ann (Aine) M. Hanly, EVP and Chief Technology Officer, will leave Vir Biotechnology on February 26, 2025.
- Maninder Hora, Ph.D. appointed as EVP and Chief Technical Operations Officer, effective February 27, 2025.
- Dr. Hora will assume all responsibilities formerly held by Dr. Hanly.

## SEC filing metadata
- accession: 0001628280-25-003073
- form_type: 8-K
- ticker: VIR
- cik: 0001706431
- company_name: Vir Biotechnology, Inc.
- filed_at: 2025-01-30T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1706431/000162828025003073/0001628280-25-003073-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1706431/000162828025003073/vir-20250124.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-003073
- JSON: https://secwatch.observer/filing/0001628280-25-003073.json
- Plain text: https://secwatch.observer/filing/0001628280-25-003073.txt

## Source-grounded claims
- claim_id: 50495bb6c7
  claim: Ann (Aine) M. Hanly departed as Executive Vice President and Chief Technology Officer at Vir Biotechnology, Inc..
  evidence_excerpt: On January 24, 2025, Vir Biotechnology, Inc. (the “Company”) announced that Ann (Aine) M. Hanly, Ph.D., the Company’s Executive Vice President and Chief Technology Officer, will be leaving the Company on February 26, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1706431/000162828025003073/0001628280-25-003073-index.htm
- claim_id: e18bb5049c
  claim: Maninder Hora was appointed as Executive Vice President and Chief Technical Operations Officer at Vir Biotechnology, Inc..
  evidence_excerpt: The Company has appointed Maninder Hora, Ph.D. to the role of Executive Vice President and Chief Technical Operations Officer, effective February 27, 2025, and Dr. Hora will assume Dr. Hanly’s responsibilities.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1706431/000162828025003073/0001628280-25-003073-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.